Description
The antibody can be combined with an IL-17A antigen highly specifically, has very high appetency and very low immunogenicity and can be used for preparing medicines for preventing or treating IL-17A-related diseases, such as various inflammations or autoimmune diseases.
Target
IL17A
Target Alias Name
Interleukin 17A
Isotype/Mimetic
Humanized IgG
Animal-Derived Biomaterials Used
None
Sequence Available
No
Original Discovery Method
Human-derived phage display
Original Discovery Information Provided On Datasheet
No
Antibody/Binder Origins
Animal-free discovery, In vitro recombinant expression